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SYMPATHETIC AND SENSORY INNERVATION AND ACTIVATION OF INGUINAL
AND EPIDIDYMAL WHITE ADIPOSE TISSUE
by
JENNIFER MENDEZ
Under the Direction of Aaron Roseberry, PhD

ABSTRACT
Studies have suggested the possibility that there is sensory (SS) afferent signaling
from white adipose tissue (WAT) to the brain, which may play an important role in
communication with the brain sympathetic nervous system (SNS) outflow to WAT. Therefore,
we tested whether the SNS-SS feedback loop between the subcutaneous inguinal WAT (IWAT)
and the epididymal WAT (EWAT) exists. These fat pads were chosen due to 1) their divergent
role in manifestation of metabolic disorders with the IWAT being beneficial and the EWAT
being detrimental, as well as 2) different lipolytic response to glucoprivic 2-deoxyglucose
(2DG). By using retrograde tract tracers Fast Blue (FB) and Fluorogold (FG), we found that the
IWAT is more innervated than EWAT by both the SS and SNS ganglia (T13-L3). Surprisingly,
we found ~12-17% of double-labeled cells in the SNS and SS ganglia innervating fat depots,
implying SNS-SS crosstalk loops between the IWAT and EWAT. Increased neuronal activation
by 2DG was observed in the SNS ganglia to both IWAT and EWAT but not in the SS dorsal root
ganglia. In addition, 2DG induced lipolysis in both fat pads with greater lipolytic properties in
the IWAT as a result of higher density of the SNS-SS fibers. Collectively, our results show
neuroanatomical reality of the IWAT and EWAT SNS-SS neural crosstalk with a coordinated
control of lipolytic function.
INDEX WORDS: Lipolysis, 2-deoxyglucose, c-Fos, Fast Blue, Fluorogold, Dorsal root ganglia
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1
1.1

INTRODUCTION

Background
Today, approximately 30% of the world’s population are either obese or overweight and

the number has doubled since 1980 (24). In 2012, in the U.S. alone, more than one third of the
population were considered obese (26). Obesity is the cause a variety of secondary health
consequences such as cardiovascular disease, type II diabetes, stroke, hypertension (17, 27, 28,
40). Along with these health consequences come an economic burden. In 2008, the U.S medical
costs associated with this disease was estimated to be $147 billion dollars(15). Obesity can result
from a variety of factors including genetics and behavior. Most commonly it is due to excess
energy being consumed compared to that which is being expended. In mammals, the majority of
surplus energy is being stored in the form of triacylglycerols (TAGs) in various WAT depots
which are located subcutaneously, around the upper and lower body regions and abdomen, as
well as internally around vital organs.
1.2

Lipolysis induced by the SNS
During times of increased energy demands lipid mobilization occurs. The sufficiency of

the activation of the sympathetic nervous system (SNS) innervation of WAT for lipid
mobilization was demonstrated in ex vivo studies with electrical stimulation of the intact SNS
nerves innervating EWAT which resulted in increased concentration of free fatty acids in the
incubation medium (13). In addition, it was demonstrated that the removal of the sole source of
circulating epinephrine by bilateral demedullation fails to block lipolysis (2, 14) whereas the
SNS innervation of WAT is sufficient and necessary for the beginning of lipolysis. The SNS
postganglionic nerves release norepinephrine (NE) which binds to beta adrenergic receptors (βAR), which further activates a cascade of intercellular signaling events initiating lipolysis, thus

2

the SNS is the principal initiator for lipolysis and the balance between the stimulation of lipolysis
by β-ARs and its inhibition by α2-AR imposes the degree of lipolysis(12, 18). When NE binds to
β3-ARs it activates the G coupled GTP binding protein GS. This activation increases cAMP by
activating adenylyl cyclase and results in stimulation of protein kinase A (PKA) which
phosphorylates two key players in lipolysis, hormone sensitive lipase (HSL) and perilipin A (1,
11, 19), an adipocyte bound protein that prevents hydrolysis of the stored fat. When perilipin A
is phosphorylated, it acts as a scaffolding protein exposing the lipid droplet for the translocation
of HSL (30) from the cytoplasm to the cell wall, to facilitate in lipolysis to undergo hydrolysis of
triacylglycerol to result in free fatty acids (FFAs) and glycerol. There are two rate-limiting
enzymes considered for lipolysis, which have different intracellular cascades for the hydrolysis
of TAG. For stimulated lipolysis (i.e., SNS/NE-stimulated) pHSL is the rate-limiting enzyme
whereas under basal lipolysis (i.e., non-SNS/NE-stimulated) ATGL is the rate-limiting enzyme.
During stimulated lipolysis ATGL assists in hydrolysis of TAG by removing, a FA to produce
diacylgylercol (DAG), which frees another FA by pHSL to produce monoacylglycerol (MAG),
where the last FA is removed by MAG lipase.

1.3

SNS Innervation of WAT

The mobilization of WAT is not homogenous, lipolysis occurs at different lipolytic rates,
depending primarily on where the adipose tissue is located. We observed this while studying the
reversal of a naturally-occurring seasonal obesity in Siberian hamsters where obesity (body fat of
~50%) induced by long summer days is reversed when exposed to short “winter-like” days (body
fat of ~20%) (5, 8, 22, 37). Internal WAT pads [e.g., retroperitoneal WAT (RWAT), and
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epididymal WAT (EWAT)] are mobilized at a higher degree compared to the externally located
subcutaneous WAT [e.g., dorsosubcutaneous WAT (DWAT), and inguinal WAT (IWAT) (3, 6,
7). The SNS innervation of WAT was demonstrated histologically, with innervation of the SNS
marker tyrosin hydroxylase (TH) immunoreactivity (-ir) (33). Direct evidence of the SNS
innervation was observed in the postganglionic SNS ganglia by the monosynatpic retrograde
tract tracer, Fluorogold (FG), both intra-IWAT and intra-EWAT(38). Functionally, selective
surgical and chemical SNS denervation of WAT completely blocks lipolysis emphasizing the
master role of the SNS innervation in triggering lipolytic responses (4, 39). Using a retrograde
viral tract tracer, pseudorabies (PRV), we previously identified the central origins of the SNS
outflow to WAT by, in Siberian hamsters (2, 34, 35) and Sprague-Dawley rats (2). This has
further been investigated in various fat pads including IWAT, EWAT, RWAT, and MWAT (4, 9,
25, 29, 31). Collectively, our viral studies revealed a number of the central sites implicated in the
SNS efferent outflow to above-mentioned fat pads as well as sensory system (SS) afferent inflow
from those fat pads to the brain (2, 29). Importantly, many areas contained both PRV152 and
H129 (SNS + SS colocalization) viruses suggesting long SNS-SS feedback circuits (2, 9, 29).
Notably, some areas exhibited greater levels of infection indicating SNS drive from the brain to
WAT is fat pad-specific. In concordance with this, we later confirmed differential SNS drives to
WAT by measuring NE turnover (NETO) levels in Siberian hamsters in response to various
metabolic stimuli (10) (i.e., cold exposure, food deprivation, glucoprivation, and central
stimulation with melanocortins).

4

1.4

SS Innervation of WAT
Histologically, two proven sensory neuropeptides, substance P and calcitonin gene-

related peptide (CGRP), was found in the WAT of Sprague Dawley rats while CGRP was found
in the IWAT and EWAT of the Siberian hamster, inferring WAT innervation by the SS (32, 33).
However, direct evidence of the SS innervation of WAT was first observed after injecting the
retrograde tract tracer, True Blue, into the IWAT and DWAT of laboratory rats which resulted in
labeling of pseudounipolar neurons in DRG associated with the concrete fat depot (16).
Recently, more focus has been on understanding the SS role in WAT brain communication.
Using the same conventional tract tracer and viral methodology, we revealed the central SS
circuits from WAT of not only Siberian hamsters, but of Sprague-Dawley rats as well (16, 23,
29). There is strong evidence suggesting that neural feedback loops may exist between WAT SS
afferents from and the SNS efferents to WAT. This was demonstrated by identifying the SS
innervation from WAT to the brain that shared many identical sites across the neuroaxis with the
neurons sending the SNS outflow to WAT (25, 29, 36). Studies involving excitatory effect of
adipokine leptin on the SS afferents emanating from WAT, support the suggestion that leptin
plays a novel role as a SS paracrine factor in WAT by informing the brain of lipid stores in WAT
and does so in a fat pad-specific manner (23). It is also suggested that lipolysis within WAT may
activate the SS afferent signaling. In support of the latter, intraperitoneal (i.p.) injections of 2deoxyglucose (2DG) a non-metabolizable glucose analog, and intra-WAT injections CL, a betaadrenergic agonist, rapidly increase neurophysiological spike activity in WAT SS fibers (36). In
this regard, surgical removal or the SS denervation of one fat depot followed by compensatory
increase in fat mass across the remaining fat depots emphasizes the importance of the SS
signaling (20, 32).
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1.5

Purpose of experiment
Because it is known that IWAT and EWAT respond to lipolytic stimuli differently and

are located differently in the hamsters, these two are a good model to study activation of the SS
and SNS innervation of WAT. In our previous studies, the use of Fast Blue (FB) and Fluorogold
(FG) tract tracing enabled us to identify mostly separate SNS innervation within the IWAT and
EWAT. Here, we hypothesize that IWAT as well as EWAT both will share SS and SNS
innervation. When given the lipolytic stimuli, 2DG, IWAT has a higher SNS drive compared to
that of EWAT (10), implying that the first should have a higher SNS neuronal activation and as a
result, a higher lipolytic rate. Additionally, given that the SS afferent signaling from WAT to the
brain may inform the brain of lipid stores within WAT (23), we hypothesize that the greater SNS
drive to IWAT might result in greater SS feedback.
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2

MATERIALS AND METHODS

All procedures were approved by the Georgia State University Institutional Animal Care and
Use Committee and are in concordance with Public Health Service and United States
Department of Agriculture guidelines.

2.1

Animal Model
Adult male Siberian hamsters, (Phodopus sungorus, ~3-4 mo old) were single-housed

after being selected from our breeding colony. Animals were kept in a long day photoperiod
(16:8-h light-dark cycle) at 21 ± 2 °C, with relative humidity at 50 ± 10%) with ad libitum access
to water and rodent chow. Hamsters were single-housed for 7–10 days before all procedures.

2.2

SNS and SS innervation of WAT
Siberian hamsters (n = 36) were anesthetized with 2% isoflurane. The skin around the

haunch area over the IWAT pad was shaved and wiped with 70% ethanol and then 10%
povidone iodine solution (Ricca Chemical, Arlington, TX) repeatedly, finishing with povidone
iodine. An incision was made around this haunch to expose the IWAT. Similarly, we made an
incision in the peritoneal wall close to the EWAT to expose the fat pad for injections. Once
exposed, fat pads were maintained moist for the entire procedure. The two tract tracers, 2% FG
(Fluorochrome, Denver, CO) and 1% FB (EMS-CHEMIE GmbH, Gross-Umstadt) were injected
unilaterally into eight separate sites across the IWAT pad (1 μl per locus for a total of 8 μl) and
into six separate sites across the EWAT pad (1 μl per locus totaling 6 μl). After each injection,
the needle was held in place for 1 min to minimize reflux up the outside of the needle. The
peritoneal wall was closed with sterile sutures and the skin incision was closed with sterile
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wound clips. In order to minimize the risk of bacterial infection nitrofurozone (nz Puffer; Hess &
Clark) was applied locally on the incision. To ensure proper labeling, tracers were switched
between each group to account for differential labeling between tracers. Two weeks post
injections of tracers hamsters were perfused for histological analyses as described below.

2.3

SNS and SS activation of WAT
Hamsters (n=36) were divided into three groups based on an average body weight of ~40 g.

On the day of the procedure, animals were transferred to the experimental room and were
allowed to acclimate for at least 2 h to reduce any stress associated with the transfer. After
acclimation, animals were depouched and food deprived. Two hours later the animals were given
the appropriate treatment of i.p. injections of saline or 2-DG (500 mg/kg or 1000 mg/kg). The 2
hour period post depouching was performed to minimize any disruption in sympathetic activity
due to the depouching.
2.4

Histological preparation and harvesting of ganglia
Hamsters were overdosed with pentobarbital sodium (300 mg/kg ip) and perfused

transcardially with heparinized (0.9%) saline and paraformaldehyde (4%) in 0.1 M phosphate
buffer (pH 7.4). DRG and the SNS ganglia associated with spinal vertebrae T12-L3 were
carefully removed and debrided from the epineurium, post fixed in the same fixative for 20 min,
and then transferred to a sucrose solution (18%) with 0.1% sodium azide where it was stored at 4
°C for 2 d. The ganglia were sectioned longitudinally at 20 μm on a freezing stage cryostat and
collected onto gel-coated slides (Superfrost Plus, VWR International, West Chester, PA) in a
series of three (with every forth section on the same slide), immediately after being sliced and
stored at 4 °C until processing for immunohistochemistry (IHC).
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2.5

c-Fos and Fluorogold IHC
The ganglia sections were rinsed in PBS (3 ×10 min), followed by a 1 h incubation in 5%

normal horse serum (NHS) (1:200; Vector Laboratories, Burlingame, CA) in PBTx (PBS
containing 0.3% Triton X-100). Sections were then incubated in primary rabbit anti-c-Fos (1:500
for DRG and 1:2000 for SNS ganglia; sc-52; Santa Cruz Biotech, Santa Cruz, CA) antibody with
10% NHS in PBTx with 0.3% sodium azide for 2 d at 4 °C. Next, the sections were rinsed with
PBS (3×15 min), then incubated for 3 h in Alexa 594 conjugated streptavidin anti rabbit (1:400;
Molecular Probes, Eugene, OR) with 10% NHS in PBTx with at 4 °C. For IHC controls, the
primary antibody was either omitted or reabsorbed with the immunizing peptide overnight at 4
°C thus resulting in negative immunostaining (data not shown). Following subsequent rinses
with PBS (4×15 min), the sections were incubated in another primary rabbit anti Fluorogold
(1:20,000; Fluorochrome, Denver, CO) antibody followed by the secondary Alexa 488
conjugated streptavidin anti rabbit (1:400; Molecular Probes, Eugene, OR) antibody. Sections
were cover slipped using ProLong Gold Antifade Reagent (Molecular Probes) for future analysis
and quantification.

2.6

Western blot analysis
For the western blot experiment, IWAT and EWAT were immediately excised from

animals after injection with pentobarbital sodium (300 mg/kg) prior to perfusion. Tissues were
then snap frozen with liquid nitrogen and stored at -80 °C until processed. The fat pads were then
minced and placed in a microcentrifuge tube containing zirconium oxide beads and a 2:1 ratio of
Homogenization buffer [50 mM HEPES, 100 mM NaCl, 10 % SDS, 2 mM EDTA, 0.5 mM
DTT, 1 mM benzamidine] and both protease inhibitor cocktail (Calbiochem, EMD Chemicals,
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Gibbstown, NJ), and phosphatase inhibitor cocktail (Thermo Fischer Scientific, Rockford, IL).
Tubes were inserted into the bullet blender for 2 x 1 min to break down the tissue and then
centrifuged for 10 min at 13,000xg. The supernatant was then collected and extra aliquots were
stored in -80 °C for future use. Protein concentration for each sample was determined by
bicinchoninic acid protein assay kit (Thermo Fisher Scientific, Rockford, IL) and used to
determine the amount of 4X Loading buffer and Millipore water to add to 10 μg of protein
sample for SDS processing. The samples were then heated at 95 °C for 5 min, loaded on to a
low-bis SDS-PAGE [10.0 %:0.08 % acrylamide:bis] and then underwent electrophoresis. The gel
was then transferred to PVDF membranes for immunoblotting. Once immunoblotting was
completed each membrane was cut in the designated area so that we could stain for the specific
protein (pHSL, HSL, and the beta actin). Membranes were washed 2x10 min in Tris-buffered
saline (TBS), blocked for 2 h in a in a blocking solution (4% nonfat dry milk in TBS), then
incubated for 48 h in a primary antibody of either HSL, pHSL and β-actin (each 1:1000; Cell
Signaling Technology, Danvers, MA) at 4 °C. After primary antibody incubation membranes
were washed 3x5 min with TTBS, then incubated in secondary goat anti-rabbit IgG HRP-linked
antibody, 1:1000; Cell Signaling Technology, Danvers, MA) for 2 h at 4 °C. The membranes
were rinsed 3x10 min in TBST and then incubated with LumiGLO chemiluminescent kit (Cell
Signaling Technology, Danvers, MA) to visualize bands on a gel imager.
2.7

Quantitative and statistical analysis
The intensity of Western blot bands was quantified based on optical densitometry

measurements using ImageJ (US National Institutes of Health, Bethesda, MA). Ratio values of
proteins and the controls, pHSL/actin and HSL/actin, were collected and then used for the ratio
of total pHSL/HSL.
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Images were view and captured under 100X and 200X magnification with the Olympus
BX41 microscope and the appropriate filters for FB, Alexa 594, and Alexa 488. FB, FG, and cFos-ir neurons were considered positive based on cell size, shape, and fluorescent intensity. The
acquired images were adjusted by contrast, brightness, sharpness, and overlaying of doublelabeled neurons by Adobe 250 Photoshop CS5 (Adobe Systems, San Jose, CA, USA).
All statistical analysis were carried out using NCSS (version 2007, Kaysville, UT). Data
were analyzed by one-way repeated measures analysis of variance (ANOVA) followed by the
post-hoc Bonferroni’s and Holm-Sidak’s tests using. Statistical significance was set at P<0.05
and all values are presented as mean ±standard error of the mean.
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3
3.1

RESULTS

SS Innervation and Activation of WAT
The dual microinjections of the conventional tract tracers FG and FB intra-IWAT and

intra-EWAT appeared at the T12-L3 DRG (Fig. 2). Total numbers of single-labeled as well as
double-labeled cells in the DRG innervating fat pads, were given as an absolute numbers and
their total percentages (Fig 2A, B). The DRG exhibited a differential pattern of innervation from
both fat pads with the most innervation coming from the lumbar L1-L3 (Fig 2B). The number of
DRG single labeled neurons innervating IWAT was significantly greater as compared with that
innervating EWAT at T13-L3 (P<0.05; Fig. 2B) with ~2-fold (P<0.05; Fig. 2C). In addition, the
percentages of single labeled neurons were significantly greater in DRG associated with the
IWAT as compared with EWAT at T12-L3 (P<0.05; Fig. 2A). Notably, the percentile number of
double-labeled cells innervating both fad pads, was ~12-17% for each SS ganglia (Fig 2B).
The number of c-Fos-ir cells in FG (from EWAT) and FB (from IWAT) labeled neurons
were distributed across T12-L3 DRG (Fig. 3). Both doses of 2DG used in the study failed to
induce neuronal activation in the DRG innervating the IWAT except for the L3 ganglion where
2DG at 500 mg/kg tended to significantly increase the percentile number of neurons compared
with the saline group (p=0.059; Fig. 3A). Notably, the percentile number of activated neurons, as
indicated by c-Fos immunostaining related to the highest 2DG dose (1000 mg/kg), was markedly
lower as compared to the lower dosage (p<0.05; Fig. 3A). Similarly, there were no significant
alterations in the numbers of c-Fos-ir cells innervating the EWAT for the only exception of L1
DRG where both doses of 2DG significantly decreased c-Fos-ir in comparison with that in the
saline group (p<0.05; Fig. 3B).
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3.2

SNS Innervation and Activation of WAT
The dual microinjections of the conventional tract tracers FG and FB intra-IWAT and

intra-EWAT appeared at the T12-L3 SNS ganglia (Fig. 5). Total numbers of single-labeled as
well as double-labeled cells in the SNS ganglia innervating fat pads, were given as an absolute
numbers and their total percentages (Fig 5A, B). The SNS exhibited a differential pattern of
innervation from both fat pads with the most innervation coming from the lumbar T13-L2 (Fig
5B). The number single labeled neurons in the SNS ganglia innervating IWAT were
significantly greater as compared with that innervating EWAT at L1-L2 (P<0.05; Fig. 5B) with
~2-fold (P<0.05; Fig. 5C). ). In addition, the percentages of single labeled neurons were
significantly greater in DRG associated with the IWAT as compared with EWAT at T12-L3
(P<0.05; Fig. 5A). In addition, the percentile number of double-labeled cells innervating both fad
pads was ~12-16% for each SNS ganglia (Fig 5B).
The number of c-Fos-ir cells in FG (from EWAT) and FB (from IWAT) labeled neurons
were distributed across T12-L3 DRG (Fig. 6). 2DG induced a dose response increase of
activation in the SNS to IWAT in ganglia T13 (p < 0.05, Fig 6A). Additionally, in IWAT, both
dosages of 2DG (500 mg/kg and 1000 mg/kg) had a significant increase in SNS activation
compared to the control group in SNS ganglia L1 (p < 0.05, Fig 6A). EWAT exhibited a
significant increase in SNS activation in both T13 and L1 in the high dose of 2DG compared to
the saline group as well as in T13 compared with the low dose of 2DG (p < 0.05, Fig 6B). 2DG
at1000 mg/kg, but not at 500 mg/kg, significantly increased c-Fos-ir in double labeled cells at
T13 SNS ganglion in comparison with the control group (p < 0.05, Fig 6C).
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3.3

Effect of 2DG on Lypolytic Activity in the WAT
To ensure that 2DG was metabolizing in the animals accordingly we measured the blood

glucose levels (Fig 7). Both doses of 2DG (500 mg/kg and 1000 mg/kg) significantly increased
blood glucose levels in a dose-dependent manner with the highest increase by the latter dose
(p<0.05; Fig. 7). Both IWAT and EWAT exhibited a dose-dependent significant increase in
lipolysis indicated by the pHSL/HSL ratios compared with the saline group and this increase was
significantly greater in the IWAT in comparison to EWAT for each treatment doses of 2DG
(p<0.05; Fig. 8D). There were no significant change in lipolysis following the saline treatment
(p<0.05; Fig. 8D). The percent values of pHSL/HSL had the same pattern; that is, 2DG dosedependently and markedly increased lipolysis in the WAT with the higher increase in the IWAT
(p<0.05; Fig 8C). In addition, Saline administration did not have any effect on lipolysis in both
fat depots (Fig. 8C).
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Figure 1: Representative picture of Innervation and Activation of DRG to WAT.
Photomicrograph illustrating labeling Sensory ganglia (DRG) L1 at 200X. Labeling of DRG
after tract tracer injections in IWAT (blue) and EWAT (green). 2DG induced activation of DRG
neurons a-d: Saline group, e-h: 2-DG 500mg/kg, i-l: 2-DG 1000 mg/kg. Scale bars = 50 μm.
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Figure 2: Distribution of SS Innervation of DRG to WAT.
Distribution of IWAT and EWAT labeled cells in the DRG at the vertebral level T13-L3. A: Total
percent of IWAT and EWAT. B: Total neuronal number of IWAT and EWAT. C: Quantification
of percent total labeled SS innervated neurons to IWAT and EWAT. *P<0.05 vs IWAT, #P<0.05
vs EWAT.
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Figure 3: Distribution of SS Activation of DRG to WAT.
2DG induced activation of DRG neurons innervating WAT at the vertebral level T13-L3. A:
Percent of c-Fos-ir positive neurons innervating IWAT. B: Percent of c-Fos-ir positive neurons
innervating EWAT C: Percent of c-Fos-ir positive neurons innervating IWAT+IWAT DB labeled
cells*P<0.05 vs Saline, #P<0.05 vs 500mg/kg 2DG.
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Figure 4: Representative picture of Innervation and Activation of Sympathetic Ganglia to
WAT.
Photomicrograph illustrating labeling sympathetic ganglia (DRG) T13 at 200X. Labeling of
sympathetic ganglia after tract tracer injections in IWAT (blue) and EWAT (green). 2DG
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induced activation of sympathetic ganglia. a-d: Saline group, e-h: 2-DG 500mg/kg, i-l: 2-DG
1000 mg/kg. Scale bars = 50 μm.

Figure 5: Distribution of SNS Innervation of Sympathetic Ganglia to WAT.
Distribution of IWAT and EWAT labeled cells in the SNS ganglia at the vertebral level T13-L3.
A: Total percent of IWAT and EWAT. B: Total neuronal number of IWAT and EWAT. C:
Quantification of percent total SNS labeled neurons to IWAT and EWAT. *P<0.05 vs IWAT,
#P<0.05 vs EWAT.
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Figure 6: Distribution of SNS Activation of Sympathetic Ganglia to WAT.
2DG induced activation of SNS neurons innervating WAT at the vertebral level T13-L3. A:
Percent of c-Fos-ir positive neurons innervating IWAT. B: Percent of c-Fos-ir positive neurons
innervating EWAT C: Percent of c-Fos-ir positive neurons innervating IWAT+IWAT DB labeled
cells*P<0.05 vs Saline, #P<0.05 vs 500mg/kg 2DG.
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Figure 7: Plasma Glucose.
Plasma glucose from hamsters given i.p injections of 500 mg/ kg and 1000 mg/kg 2DG and
saline vehicle. *P<0.05 vs Saline, #P<0.05 vs 500mg/kg.

Figure 8: Western blot analysis of WAT.
Western blot analysis of HSL and pHSL in IWAT and EWAT with 2DG treatment A. Immunoblot
of pHSL, HSL, and beta-actin protein bands in IWAT. B Immunoblot of pHSL, HSL, and beta-
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actin protein bands in EWAT. C: Western blot with ratio of HSL/pHSL taken as percent of saline.
D: Western blot with ratio of HSL/pHSL taken as ratio *P<0.05 vs Saline, #P<0.05 vs
500mg/kg.
4

DISCUSSION

Collectively, using two distinct monosynaptic retrograde tract tracers, FG and FB, we for
the first time revealed separate and shared innervation of both IWAT and EWAT of Siberian
hamsters by the SNS and SS ganglia. Our results suggest that IWAT is more innervated than
EWAT by both the SS and SNS. We also showed that 2DG dose-dependently increased the SNS
drive to the WAT up to two hours with faded activation in the SS ganglia, implying the initial SS
role in sensing the SNS drive. The higher innervation of the IWAT resulted in higher SNS drive
and, thus, lipolytic rate within the IWAT compared with the EWAT, which support the notion of
faster fat mobilization in the subcutaneous over inner fat depots.
In agreement with the innervation study of IWAT and EWAT (38), we showed similar
separate patterns of innervation by the SNS ganglia. Our tracing studies indicated more
innervation of IWAT at T13 and L1 ganglia in concordance with the above-mentioned study;
however, we did not confirm higher EWAT innervation emanating from L2 or L3 ganglia. Our
results showed that both the total number and percentage of innervation SNS innervation to
IWAT was greater for each ganglia analyzed. The dissimilarities between the two studies could
arise from the difference in the amount of tracer injected in which IWAT was treated (5 μl
previously vs 8 μl in the current study). The SS innervation of the IWAT and EWAT were
similar to that of the SNS innervation of the IWAT being most innervated in all the ganglia in
comparison to the EWAT. Our results demonstrated, that the IWAT appeared to be ~2-fold more
innervated as compared with the EWAT by both the SS and SNS. Interestingly, we found that
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both the SNS and SS ganglia contained roughly equal number of doubly labeled neurons (~1217%) showing neuroanatomical evidence of crosstalk between two fat depots.
We previously showed that 2DG rapidly activates sensory afferents within 5-10 minutes
(36) indicating that sensory afferents could sense some aspects of lipolysis. In this study, we
observed increased SNS activation up to two hours after 2DG administration but not in the SS.
Activation in the SNS peaks at two hours post systemic 2DG (21); however, this may not be
optimal for the SS if they are primarily activated. At two hours, the activation of the SS
affertents of WAT may have exhibited diminished effects. The SNS drive to the WAT is not
uniform and, previously, we found that 2DG differently affects lipolysis in different fat depots
(10).That is, NETO/lipolysis increases responding to 2DG treatment occur specifically in the
IWAT but not in the EWAT when we used 2DG at 500 mg/kg (10). Nevertheless, in the current
study we demonstrated that the higher 2DG dose (1000 mg/kg) is capable to trigger lipolysis.
Therefore, we conclude that the EWAT may possess a higher threshold to 2DG in order
to initiate lipolysis. In addition to establishing SNS activation we measured the lipolytic
properties within both IWAT and EWAT by examining the ratio of pHSL and HSL, in vivo
markers of lipolysis, for each fat pad after 2DG. We showed a significant dose-dependent
increase of lipolysis in both the IWAT and EWAT in response to 2DG stimulus. Increases in the
SNS activation to both IWAT and EWAT were exhibited specifically in T13 and L1 ganglia. The
lipolytic rate in the IWAT was approximately two times greater than in the EWAT for both 2DG
treatment groups. It appears that more adipocytes from IWAT-SNS and SS innervation
contributed to higher lipolytic response, thus supporting the notion of trivial dichotomic
distinctions between the faster mobilized subcutaneous WAT and slower mobilized visceral
WAT.
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Collectively, our results show persuasive evidence of the IWAT and EWAT SNS-SS
neural crosstalk with a coordinated control of lipolytic function. Additionally, we demonstrated
that the IWAT appeared to be profoundly more innervated by either the SNS or the SS, thus,
indicating higher lipolityc capacities of the subcutaneous WAT in response to 2DG. Finally, our
tracing studies combined with the c-Fos immunostaining revealed specific ganglia contributing
to the innervation of both fat depots, therefore, providing a model system with which to
determine the lipolytic properties of distinct fat pad in response to various metabolic stimuli,
such as glucoprivation, cold exposure and starvation. It is our hope that further understanding of
the SNS-SS interaction in relation with WAT innervations could shed light on the intrinsic nature
of WAT to maximize fat mobilization to reverse obesity and associated metabolic diseases.
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